Profiel
Andrew Jefferson is currently an Operating Partner at Versant Ventures (Switzerland) GmbH since 2022.
Formerly, Mr. Jefferson was Chief Operating Officer at Monte Rosa Therapeutics, Inc. Mr. Jefferson completed an undergraduate degree at The University of Nottingham in 1990 and earned an MBA from the University of Brighton in 1999.
Actieve functies van Andrew Jefferson
| Bedrijven | Functie | Begin |
|---|---|---|
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01-07-2022 |
Eerdere bekende functies van Andrew Jefferson
| Bedrijven | Functie | Einde |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Operationeel Directeur | - |
Opleiding van Andrew Jefferson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The University of Nottingham
The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Brighton
University of Brighton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
















